RE:RE:The Board Great board, hoping to see who they elect as CEO.
At this point, I do not believe the disapproval of Aducanumab in June will have any major impact on SP.
If approved, we will definitely see an increase, possibly a few basis points. .
Curious as to what others think on Aducanumab and Biogens readiness for Approval (Swiss Lab).